Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 407 results for "Cgix"

Why Cancer Genetics (CGIX) Stock Might be a Great Pick - Tale ...

One stock that might be an intriguing choice for investors right now is Cancer Genetics, Inc. (CGIX). This is because this security in the medical services space is seeing solid earnings estimate revision activity, and is in great company from a ... Yahoo! Finance, 1 month ago

Insider Trading Alert - CGIX, NI And XNCR Traded By Insiders

Reddit Email Reprint Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer. Yesterday, June 15, 2015, 81 U.S.
 TheStreet.com2 months ago

Cancer Genetics to Present a Unique, Comprehensive NGS-Based Lymphoma Panel at Cancer Genomics Consortium and Cytogenomics Array Group Meeting

GlobeNewswire 2015-08-03RUTHERFORD, N.J., Aug. 3, 2015 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "The Company"), an emerging leader in DNA-based cancer diagnostics, announced today the first scientific presentation of the ...
 BizWire Express3 weeks ago Mid-Day Changers: Cancer Genetics, Inc. (CGIX), ProShares Ultra Bloomberg Crude Oil (UCO), Fresh Del Monte Produce Inc. (FDP), Kingold Jewelry, Inc. (KGJI), Blueknight Energy Partners, L.P. (BKEP)  WallStreetScope.com1 month ago Cancer Genetics, Inc. (CGIX) Announced Today That It Has Suspended Its Activity On The "At-The-Market" Equity Offering 7/24/2015  ClinicSpace1 month ago Cancer Genetics, Inc. Announced Today That it Has Suspended Its Activity on the "At-The-Market" Equity Offering  Yahoo! 7 Finance1 month ago

How Will Cancer Genetics (NASDAQ:CGIX) Stock React To Zacks's Upgrade to hold from buy?

Cancer Genetics (NASDAQ:CGIX) Change of Rating In analysts note revealed to investors on 13 August, equity analysts at Zacks's equities research division upped Cancer Genetics (NASDAQ:CGIX)'s stock from buy to hold. They have a PT of $12.00 on ...
 Octafinance1 week ago Cancer Genetics Rating Increased to Buy at Zacks (CGIX)  WKRB News3 weeks ago Cancer Genetics Upgraded by Zacks to Buy (CGIX)  SleekMoney4 weeks ago Cancer Genetics Raised to Buy at Zacks (CGIX)  Ticker Report4 weeks ago

Cancer Genetics reports Q2 results

8/11/2015, 1:54 PM (Source: Seeking Alpha) Cancer Genetics (CGIX +1.6% ) Q2 results : Revenues: $4.2M (+180.0%); COGS: $3.1M (+106.7%); R&D Expense: $1.3M (+18.2%); SG&A: $4.2M (+27.3%); Operating Loss: ($4.4M) (unch); ...
 TeleTrader.com2 weeks ago Cancer Genetics EPS in-line, misses on revenue  TeleTrader.com2 weeks ago

Cancer Genetics Lowered to Hold at Zacks (CGIX)

Zacks lowered shares of Cancer Genetics (NASDAQ:CGIX) from a buy rating to a hold rating in a research report released on Wednesday morning, MarketBeat reports. According to Zacks, Cancer Genetics, Inc. operates as a diagnostics company focused on ...
 Mideast Time4 weeks ago Cancer Genetics Downgraded by Zacks (CGIX)  Ticker Report1 month ago
Ticker Report

Stock Analysts Downgrades for July, 29th (AHL, ALDW, ASPU, ATVI, AUO, BKS, CAE, CGIX, CHCO, CKEC)

Stock Analysts downgrades for Wednesday, July 29th: Aspen Insurance Holdings Limited (NYSE:AHL) was downgraded by analysts at Zacks from a hold rating to a sell rating. According to Zacks, Aspen Insurance Holdings is a Bermudian holding company that ...
 Ticker Report1 month ago

Health Care Sector Update for 07/24/2015: CGIX, REPH, BIIB

PFE: flat ABT: flat MRK: flat AMGN: -1.1% Health-care shares were generally lower in pre-market trade Friday. In health-care stocks news, Cancer Genetics ( CGIX ) says it has suspended activity on the sale of shares through an "at-the-market" ...
 Nasdaq1 month ago Health Care Sector Update for 06/30/2015: MDRX, BCRX, CGIX  Nasdaq1 month ago

ICON-Cancer Genetics Partner to Offer Better Lab Solutions - Analyst Blog

Global Contract Research Organization (CRO) ICON Plc ICLR and DNA-based diagnostics provider Cancer Genetics Inc CGIX recently announced a partnership that will help them to offer superior laboratory testing solutions for oncology trials from Phase ...
 Zacks.com1 month ago

Analysts Set $14.38 Target Price for Cancer Genetics (NASDAQ:CGIX)

Shares of Cancer Genetics (NASDAQ:CGIX) have been given a consensus broker rating score of 1.00 (Strong Buy) from the two analysts that provide coverage for the company, Zacks Investment Research reports. Two research analysts have rated the stock ...
 WKRB News1 month ago Cancer Genetics Receives Consensus Recommendation of Strong Buy from Analysts (NASDAQ:CGIX)  SleekMoney2 months ago Analysts Expect Cancer Genetics to Post ($0.50) EPS (NASDAQ:CGIX)  Ticker Report2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less